Regal Investment Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.35M | Sell |
92,932
-6,772
| -7% | -$244K | 0.25% | 105 |
|
|
2025
Q1 | $3.1M | Buy |
99,704
+81,989
| +463% | +$2.55M | 0.25% | 111 |
|
|
2024
Q4 | $452K | Sell |
17,715
-11,138
| -39% | -$284K | 0.03% | 342 |
|
|
2024
Q3 | $816K | Buy |
28,853
+7,686
| +36% | +$217K | 0.06% | 276 |
|
|
2024
Q2 | $558K | Buy |
21,167
+3,700
| +21% | +$97.6K | 0.04% | 331 |
|
|
2024
Q1 | $530K | Buy |
17,467
+7,960
| +84% | +$242K | 0.04% | 349 |
|
|
2023
Q4 | $267K | Buy |
+9,507
| New | +$267K | 0.02% | 444 |
|
|
2023
Q2 | – | Sell |
-5,749
| Closed | -$207K | – | 540 |
|
|
2023
Q1 | $207K | Buy |
5,749
+29
| +0.5% | +$1.05K | 0.02% | 476 |
|
|
2022
Q4 | $226K | Buy |
5,720
+270
| +5% | +$10.7K | 0.02% | 430 |
|
|
2022
Q3 | $219K | Buy |
+5,450
| New | +$219K | 0.02% | 426 |
|